CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

Core Curriculum on Tuberculosis, 2000

Chapter 6
Treatment of Latent TB Infection (LTBI)

Selected Bibliography

Bass JB. The tuberculin test, preventive therapy, and elimination of tuberculosis. Am Rev Respir Dis 1990;141:812-813.

Fitzgerald JM, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis 1990:848-853.

Gordin FM, Matts JP, Miller C, et al. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. N Engl J Med 1997;337:315-320.

Jordan TJ, Lewit EM, Reichman LB. Isoniazid preventive therapy for tuberculosis: decision analysis considering ethnicity and gender. Am Rev Respir Dis 1991;144:1357-1360.

Koplan JP, Farer LS. Choice of preventive treatment for isoniazid-resistant tuberculous infection: use of decision analysis and the Delphi technique. JAMA 1980;244:2736-2740.

Miller B. Preventive therapy for tuberculosis. Medical Clinics of North America 1993;77:1263-1275.

Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999;281:1014-1018.

OíBrien RJ, PerriŽns JH. Preventive therapy for tuberculosis in HIV infection: the promise and the reality. AIDS 1995;9:665-673.

Passannante MR, Restifo RA, Reichman LB. Preventive therapy for the patient with both universal indication and contraindication for isoniazid. Chest 1993;103:825-831.

Snider DE. Pyridoxine supplementation during isoniazid therapy. Tubercle 1980;61:191-196.

Villarino ME, Ridzon R, Weismuller PC, et al. Rifampin preventive therapy for tuberculosis infection. Experience with 157 adolescents. Am J Respir Crit Care Med 1997;155:1735-1738.

Tuberculosis Chemotherapy Centre, Madras. The prevention and treatment of isoniazid toxicity in the therapy of pulmonary tuberculosis. II. An assessment of the prophylactic effect of pyridoxine in low dosage. Bull WHO 1963;29:457-481.

Krishnamurthy DV, Selkon JB, Ramachandran K, et al. Effect of pyridoxine on vitamin B6 concentrations and glutamic-oxaloacetic transaminase activity in whole blood of tuberculous patients receiving high-dosage isoniazid. Bull WHO 1967;36:853-870.

Centers for Disease Control and Prevention. Patient Adherence to Tuberculosis Treatment. Self-Study Modules on Tuberculosis, No. 9. Atlanta, Ga: Department of Health and Human Services, CDC; October 1999.

Centers for Disease Control and Prevention. Contact Investigations for Tuberculosis. Self-Study Modules on Tuberculosis, No. 6. Atlanta, Ga: Department of Health and Human Services, CDC; October 1999.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333